Singular Genomics Systems, Inc. (OMIC)
Largest Insider Buys in Sector
OMIC Stock Price History Chart
OMIC Stock Performance
About Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.
Insider Activity of Singular Genomics Systems, Inc.
Over the last 12 months, insiders at Singular Genomics Systems, Inc. have bought $135,252 and sold $361,986 worth of Singular Genomics Systems, Inc. stock.
On average, over the past 5 years, insiders at Singular Genomics Systems, Inc. have bought $8.37M and sold $361,986 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Glezer Eli N. (Chief Scientific Officer) — $85,640. Spaventa Andrew (Chief Executive Officer) — $49,612.
The last purchase of 75,000 shares for transaction amount of $31,755 was made by Spaventa Andrew (Chief Executive Officer) on 2023‑11‑17.
List of Insider Buy and Sell Transactions, Singular Genomics Systems, Inc.
| 2023-11-17 | Spaventa Andrew | Chief Executive Officer | 75,000 0.1012% | $0.42 | $31,755 | -2.82% | ||
| 2023-11-16 | Glezer Eli N. | Chief Scientific Officer | 200,000 0.272% | $0.43 | $85,640 | +0.08% | ||
| 2023-11-16 | Spaventa Andrew | Chief Executive Officer | 43,468 0.0567% | $0.41 | $17,857 | +0.08% | ||
| 2023-08-15 | Sale | Kamdar Kim P. | director | 200,000 0.2773% | $0.53 | $106,960 | -22.15% | |
| 2023-08-14 | Sale | Kamdar Kim P. | director | 77,991 0.1139% | $0.57 | $44,424 | -22.97% | |
| 2023-08-11 | Sale | Kamdar Kim P. | director | 353,657 0.5041% | $0.60 | $210,603 | -28.10% | |
| 2023-05-17 | Glezer Eli N. | Chief Scientific Officer | 170,000 0.2422% | $0.82 | $138,924 | -41.05% | ||
| 2022-12-12 | Glezer Eli N. | Chief Scientific Officer | 50,000 0.0743% | $2.00 | $100,000 | -53.90% | ||
| 2022-05-18 | Pellini Michael J | 26,834 0.0412% | $3.30 | $88,552 | -19.74% | |||
| 2021-06-01 | Flynn James E | 10 percent owner | 1.5M 3.3473% | $22.00 | $33M | -62.91% |
Insider Historical Profitability
| Glezer Eli N. | Chief Scientific Officer | 4570000 6.2275% | $11.10 | 3 | 0 | <0.0001% |
| Spaventa Andrew | Chief Executive Officer | 4061206 5.5341% | $11.10 | 2 | 0 | |
| Kamdar Kim P. | director | 3763985 5.1291% | $11.10 | 0 | 3 | |
| Flynn James E | 10 percent owner | 7484871 10.1995% | $11.10 | 1 | 0 | <0.0001% |
| Pellini Michael J | 99289 0.1353% | $11.10 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Deerfield Management | $2.56M | 6.73 | 4.98M | 0% | +$0 | 0.05 | |
| Arch Venture Management Llc | $1.95M | 5.13 | 3.8M | 0% | +$0 | 2.78 | |
| Qvidtvm Management Llc | $1.29M | 3.38 | 2.51M | +8.06% | +$96,182.17 | 1.09 | |
| UBS | $1.14M | 2.98 | 2.21M | +<0.01% | +$16.96 | <0.0001 | |
| Perceptive Advisors | $1.09M | 2.87 | 2.13M | 0% | +$0 | <0.01 | |
| Fidelity Investments | $1.09M | 2.86 | 2.12M | 0% | +$0 | <0.0001 | |
| The Vanguard Group | $962,882.00 | 2.53 | 1.87M | 0% | +$0 | <0.0001 | |
| Casdin Capital | $680,742.00 | 1.79 | 1.32M | 0% | +$0 | 0.05 | |
| BlackRock | $379,845.00 | 1 | 738,711 | -11.38% | -$48,789.33 | <0.0001 | |
| OrbiMed | $278,026.00 | 0.73 | 540,697 | 0% | +$0 | 0.01 | |
| Hightower Advisors | $272,000.00 | 0.71 | 528,324 | +26.3% | +$56,632.94 | <0.0001 | |
| Verition Fund Management Llc | $257,100.00 | 0.68 | 500,000 | +5.26% | +$12,855.00 | <0.01 | |
| Geode Capital Management | $236,939.00 | 0.62 | 460,639 | 0% | +$0 | <0.0001 | |
| Tikvah Management Llc | $162,926.00 | 0.43 | 316,854 | 0% | +$0 | 0.05 | |
| Triatomic Management Lp | $100,131.00 | 0.26 | 194,731 | 0% | +$0 | 1.17 | |
| Millennium Management LLC | $90,499.00 | 0.24 | 176,000 | +49.33% | +$29,895.52 | <0.0001 | |
| Bridgeway Capital Management | $62,475.00 | 0.16 | 121,500 | 0% | +$0 | <0.01 | |
| Citadel Advisors LLC | $60,120.00 | 0.16 | 116,920 | +153.78% | +$36,429.88 | <0.0001 | |
| State Street | $57,907.00 | 0.15 | 112,615 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $57,000.00 | 0.15 | 111,200 | -26.58% | -$20,631.74 | <0.0001 | |
| Squarepoint Ops LLC | $52,372.00 | 0.14 | 101,851 | -15.18% | -$9,374.93 | <0.0001 | |
| Northern Trust | $41,323.00 | 0.11 | 80,363 | 0% | +$0 | <0.0001 | |
| Weil Company Inc | $35,069.00 | 0.09 | 68,202 | -50.65% | -$35,993.52 | 0.02 | |
| Susquehanna International Group | $26,288.00 | 0.07 | 51,125 | New | +$26,288.00 | <0.0001 | |
| MSA Financial (Marino, Stram & Associates, LLC) | $20,568.00 | 0.05 | 40,000 | 0% | +$0 | 0.01 | |
| JPMorgan Chase | $19,990.00 | 0.05 | 38,815 | -25.05% | -$6,680.16 | <0.0001 | |
| Xtx Topco Ltd | $12,635.00 | 0.03 | 24,573 | -56.32% | -$16,293.41 | <0.01 | |
| Goldman Sachs | $11,092.00 | 0.03 | 21,572 | +4.52% | +$479.74 | <0.0001 | |
| Engineers Gate Manager Lp | $7,734.00 | 0.02 | 15,041 | 0% | +$0 | <0.0001 | |
| Palumbo Wealth Management | $6,453.00 | 0.02 | 12,549 | New | +$6,453.00 | <0.01 | |
| Barclays | $6,000.00 | 0.02 | 12,284 | 0% | +$0 | <0.0001 | |
| Bank of America | $5,485.00 | 0.01 | 10,672 | -0.32% | -$17.48 | <0.0001 | |
| Morgan Stanley | $4,480.00 | 0.01 | 8,712 | -0.24% | -$10.80 | <0.0001 | |
| Tower Research Capital | $3,061.00 | 0.01 | 5,955 | -12.88% | -$452.34 | <0.0001 | |
| Royal Bank of Canada | $1,000.00 | <0.01 | 2,000 | -28.67% | -$402.00 | <0.0001 | |
| RhumbLine Advisers | $854.00 | <0.01 | 1,662 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $197.00 | <0.01 | 384 | +1.86% | +$3.59 | <0.0001 | |
| Qube Research & Technologies | $351.00 | <0.01 | 682 | 0% | +$0 | <0.0001 | |
| Citigroup | $15.00 | <0.01 | 29 | 0% | +$0 | <0.0001 |